United Services Automobile Association bought a new position in Doximity, Inc. (NASDAQ:DOCS – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 8,070 shares of the company’s stock, valued at approximately $472,000.
A number of other hedge funds also recently made changes to their positions in DOCS. VSM Wealth Advisory LLC purchased a new stake in shares of Doximity in the first quarter worth about $29,000. Allworth Financial LP lifted its position in shares of Doximity by 104.0% in the first quarter. Allworth Financial LP now owns 563 shares of the company’s stock worth $32,000 after buying an additional 287 shares in the last quarter. National Bank of Canada FI purchased a new stake in shares of Doximity in the first quarter worth about $33,000. Spire Wealth Management lifted its position in shares of Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company’s stock worth $36,000 after buying an additional 260 shares in the last quarter. Finally, Brooklyn Investment Group lifted its position in shares of Doximity by 70.7% in the first quarter. Brooklyn Investment Group now owns 746 shares of the company’s stock worth $43,000 after buying an additional 309 shares in the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.
Doximity Stock Performance
DOCS opened at $69.01 on Thursday. The stock has a market cap of $12.92 billion, a price-to-earnings ratio of 69.01, a P/E/G ratio of 4.10 and a beta of 1.37. The stock’s 50 day moving average price is $63.25 and its 200-day moving average price is $59.94. Doximity, Inc. has a one year low of $36.12 and a one year high of $85.21.
Analysts Set New Price Targets
Several brokerages have weighed in on DOCS. Evercore ISI raised Doximity from an “in-line” rating to an “outperform” rating and boosted their price objective for the stock from $50.00 to $70.00 in a research note on Wednesday, July 9th. KeyCorp boosted their price objective on Doximity from $65.00 to $70.00 and gave the stock an “overweight” rating in a research note on Monday, July 14th. Zacks Research cut Doximity from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. The Goldman Sachs Group set a $50.00 price objective on Doximity and gave the stock a “neutral” rating in a research note on Wednesday, May 21st. Finally, Canaccord Genuity Group boosted their price objective on Doximity from $50.00 to $59.00 and gave the stock a “hold” rating in a research note on Friday, August 8th. Two research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat.com, Doximity presently has an average rating of “Moderate Buy” and a consensus target price of $66.21.
Get Our Latest Stock Analysis on DOCS
Insider Activity
In related news, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the sale, the director owned 16,618 shares in the company, valued at approximately $948,721.62. The trade was a 10.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy S. Cabral sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total value of $600,000.00. Following the completion of the sale, the director owned 6,360 shares of the company’s stock, valued at $381,600. The trade was a 61.12% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 32,000 shares of company stock valued at $1,929,380. 31.30% of the stock is currently owned by insiders.
Doximity Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Articles
- Five stocks we like better than Doximity
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Part of the Club: Robinhood & AppLovin Soar on S&P 500 Inclusion
- What Do S&P 500 Stocks Tell Investors About the Market?
- Despite Pullback, Rocket Lab Still Looks Primed for a Breakout
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Analyst Upgrades Strengthen Microsoft’s Long-Term Outlook
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.